ASHFORD CAPITAL MANAGEMENT INC

Position in ADMA — Adma Biologics, Inc.

CIK 897070 WILMINGTON, DE

Position in ADMA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,257,115

New position

Shares Held

361,500

first reported quarter

Ownership

0.156%

of shares outstanding

% of Portfolio

0.46%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ASHFORD CAPITAL MANAGEMENT INC holds $65,140,782 across 5 Biotechnology names. ADMA ranks #4 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	207,565	$41,440,352
2	INCY	Incyte Corp	165,247	$15,553,047
3	VRTX	Vertex Pharmaceuticals Inc / Ma	9,078	$4,053,690
4	ADMA	Adma Biologics, Inc. This page	361,500	$3,257,115
5	TECH	BIO-TECHNE Corp	16,008	$836,578

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,257,115	361,500	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.